opsumit | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
CDMO Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

Opsumit
Health Canada Patents

PharmaCompass Sponsored Ads

Contact Supplier

IOL Chemicals is an innovation-driven bulk drug, Intermediate and Specialty Chemicals company.

Contact Supplier

IKF/Pharmasynthese have been with fine chemicals market and APIs performance for more than 40 years.

Contact Supplier

medac CDMO: Tailored CDMO services for injectables in syringes, cartridges & vials – aseptic, reliable, flexible and a solution ahead.

Contact Supplier

Coral

Contact Supplier

ICE Pharma offers a unique range of bile acid products and best-in-class services for the pharmaceutical industry.

Contact Supplier

opsumit

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

37 API Suppliers, 14 USDMF, 3 EU WC, 1 KDMF, 10 NDC API, 26 Listed Suppliers, $ API Reference Price

37 API Suppliers
14 USDMF
3 EU WC
1 KDMF
10 NDC API
26 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

65 Drugs in Development

65 Drugs in Development

INTERMEDIATES

15 Intermediate Suppliers

15 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

27 FDF Dossiers, 9 FDA Orange Book, 5 Europe, 2 Canada, 4 Australia, 1 South Africa, 6 Listed Dossiers

27 FDF Dossiers
9 FDA Orange Book
5 Europe
2 Canada
4 Australia
1 South Africa
6 Listed Dossiers

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc, 1 SPI Pharma, 4 DKSH, 1 Pharm-RX Chemical, 1 Boai NKY Pharmaceuticals Ltd, 4 Gangwal Healthcare, 3 Nanjing Well Pharmaceutical, 1 Kirsch Pharma, 2 Actylis, 1 Aeon Procare, 3 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Ashland, 11 BASF, 1 CD Formulation, 5 Corel Pharma Chem, 5 DFE Pharma, 10 Gangwal Chemicals, 2 Ideal Cures, 1 Ingredion Pharma Solutions, 13 Kerry, 2 Keval Exports, 10 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nitika Pharmaceutical Specialities, 2 Novo Excipients, 3 Pharmatrans-Sanaq, 3 Pluviaendo, 3 Prachin Chemical, 11 Roquette, 6 Seppic, 2 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 10 Sigachi Industries, 3 Silverline Chemicals, 3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

35 Fillers, Diluents & Binders, 20 Coating Systems & Additives, 17 Granulation, 17 Solubilizers, 16 Direct Compression, 15 Thickeners and Stabilizers, 15 Disintegrants & Superdisintegrants, 12 Controlled & Modified Release, 12 Lubricants & Glidants, 11 Parenteral, 9 Co-Processed Excipients, 7 Film Formers & Plasticizers, 6 Topical, 5 Rheology Modifiers, 5 Emulsifying Agents, 3 Taste Masking, 3 Surfactant & Foaming Agents, 3 Chewable & Orodispersible Aids, 3 API Stability Enhancers, 2 Coloring Agents

35 Fillers, Diluents & Binders
20 Coating Systems & Additives
17 Granulation
17 Solubilizers
16 Direct Compression
15 Thickeners and Stabilizers
15 Disintegrants & Superdisintegrants
12 Controlled & Modified Release
12 Lubricants & Glidants
11 Parenteral
9 Co-Processed Excipients
7 Film Formers & Plasticizers
6 Topical
5 Rheology Modifiers
5 Emulsifying Agents
3 Taste Masking
3 Surfactant & Foaming Agents
3 Chewable & Orodispersible Aids
3 API Stability Enhancers
2 Coloring Agents

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 1 Stock Recap #PipelineProspector, 42 News #PharmaBuzz

1 Data Compilation #PharmaFlow
1 Stock Recap #PipelineProspector
42 News #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 3 Regulatory FDF Prices, 9 Annual Reports

1 US Medicaid Prescriptions
3 Regulatory FDF Prices
9 Annual Reports

MARKET PLACE

7 APIs, 3 FDF Dossiers

7 APIs
3 FDF Dossiers

PATENTS & EXCLUSIVITIES

5 US Patents, 1 US Exclusivities, 5 Health Canada Patents

5 US Patents
1 US Exclusivities
5 Health Canada Patents

REF. STANDARDS & IMPURITIES

3 USP, 1 Others

3 USP
1 Others

$ API Ref.Price (USD/KG) : 11,179 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

5 All

01 3Belmore Neidrauer LLP

02 2Blake Cassels & Graydon LLP

filter Patent Reset all filters

5 All

01 22431675

02 12621273

03 22659770

filter Product Reset all filters

5 All

01 3MACITENTAN

02 2MACITENTAN | TADALAFIL

filter Dosage Reset all filters

5 All

01 5TABLET

filter Exp Date Reset all filters

5 All

01 22021-12-04

02 12026-09-11

03 22027-08-28

Product Main Page

01

Blake Cassels & Graydon LLP

MACITENTAN

Formnext Forum

Not Confirmed

Blake Cassels & Graydon LLP

Formnext Forum

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2021-12-04

Date Granted : 2011-11-08

Brand Name : OPSUMIT

Patent Number : 2431675

Filing Date : 2001-12-04

Strength per Unit : 10 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2021-12-04

Date Granted : 2011-11-08

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

Belmore Neidrauer LLP

MACITENTAN

Formnext Forum

Not Confirmed

Belmore Neidrauer LLP

Formnext Forum

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2027-08-28

Date Granted : 2014-11-18

Brand Name : OPSUMIT

Patent Number : 2659770

Filing Date : 2007-08-28

Strength per Unit : 10 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2027-08-28

Date Granted : 2014-11-18

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

Belmore Neidrauer LLP

MACITENTAN

Formnext Forum

Not Confirmed

Belmore Neidrauer LLP

Formnext Forum

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2026-09-11

Date Granted : 2014-07-29

Brand Name : OPSUMIT

Patent Number : 2621273

Filing Date : 2006-09-11

Strength per Unit : 10 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2026-09-11

Date Granted : 2014-07-29

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

Blake Cassels & Graydon LLP

MACITENTAN, TADALAFIL

Formnext Forum

Not Confirmed

Blake Cassels & Graydon LLP

Country

Formnext Forum

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2021-12-04

Date Granted : 2011-11-08

MACITENTAN, TADALAFIL

Brand Name : OPSYNVI

Patent Number : 2431675

Filing Date : 2001-12-04

Strength per Unit : 10mg / 40mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2021-12-04

Date Granted : 2011-11-08

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

05

Belmore Neidrauer LLP

MACITENTAN, TADALAFIL

Formnext Forum

Not Confirmed

Belmore Neidrauer LLP

Country

Formnext Forum

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2027-08-28

Date Granted : 2014-11-18

MACITENTAN, TADALAFIL

Brand Name : OPSYNVI

Patent Number : 2659770

Filing Date : 2007-08-28

Strength per Unit : 10mg / 40mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2027-08-28

Date Granted : 2014-11-18

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!